Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Admon

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Critical Care Medicine|June 9, 2026
Continuing Vs. Withholding Home Beta-Blockers at Admission for Suspected Infection: A Target Trial EmulationNathaniel Christian-Miller, Kathleen Tiffany Lee, Raymond Pashun, et al.
Clinical and Translational Gastroenterology|February 28, 2023
Social Network Diversity and the Daily Burden of Inflammatory Bowel DiseaseLaVana Greene-Higgs, Ariel Jordan, Jessica Sheehan, et al.
ATS Scholar|February 2, 2023
Development and Retention of Early-Career Clinician-Scientists through a Novel Peer Mentorship Program: Multidisciplinary Intensive Care Research WorkgroupElizabeth M Viglianti, Andrew J Admon, Erin F Carlton, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 26, 2025
Sepsis Prediction Models are Trained on Labels that Diverge from Clinician-Recommended Treatment TimesGary E Weissman, Rebecca A Hubbard, Blanca E Himes, et al.
Journal of Hospital Medicine|August 23, 2021
Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity 1 Month After Hospitalization for Third-Wave COVID-19: Early Results From a US Nationwide CohortTheodore J Iwashyna, Lee A Kamphuis, Stephanie J Gundel, et al.
The American Journal of Gastroenterology|April 27, 2023
Characteristics of Facilities With Early and Rapid Ustekinumab Adoption for Patients With Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Tony Van, Jeffrey A Berinstein, et al.
Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.
Critical Care Medicine|May 7, 2024
Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial EmulationAndrew J Admon, Shirley Cohen-Mekelburg, Megan Opatrny, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic RejectionMichael P Combs, Jenna E Luth, Nicole R Falkowski, et al.
Annals of the American Thoracic Society|May 1, 2019
Emulating a Novel Clinical Trial Using Existing Observational Data. Predicting Results of the PreVent StudyAndrew J Admon, John P Donnelly, Jonathan D Casey, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Critical Care Medicine|June 9, 2026
Continuing Vs. Withholding Home Beta-Blockers at Admission for Suspected Infection: A Target Trial EmulationNathaniel Christian-Miller, Kathleen Tiffany Lee, Raymond Pashun, et al.
Clinical and Translational Gastroenterology|February 28, 2023
Social Network Diversity and the Daily Burden of Inflammatory Bowel DiseaseLaVana Greene-Higgs, Ariel Jordan, Jessica Sheehan, et al.
ATS Scholar|February 2, 2023
Development and Retention of Early-Career Clinician-Scientists through a Novel Peer Mentorship Program: Multidisciplinary Intensive Care Research WorkgroupElizabeth M Viglianti, Andrew J Admon, Erin F Carlton, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 26, 2025
Sepsis Prediction Models are Trained on Labels that Diverge from Clinician-Recommended Treatment TimesGary E Weissman, Rebecca A Hubbard, Blanca E Himes, et al.
Journal of Hospital Medicine|August 23, 2021
Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity 1 Month After Hospitalization for Third-Wave COVID-19: Early Results From a US Nationwide CohortTheodore J Iwashyna, Lee A Kamphuis, Stephanie J Gundel, et al.
The American Journal of Gastroenterology|April 27, 2023
Characteristics of Facilities With Early and Rapid Ustekinumab Adoption for Patients With Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Tony Van, Jeffrey A Berinstein, et al.
Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.
Critical Care Medicine|May 7, 2024
Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial EmulationAndrew J Admon, Shirley Cohen-Mekelburg, Megan Opatrny, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic RejectionMichael P Combs, Jenna E Luth, Nicole R Falkowski, et al.
Annals of the American Thoracic Society|May 1, 2019
Emulating a Novel Clinical Trial Using Existing Observational Data. Predicting Results of the PreVent StudyAndrew J Admon, John P Donnelly, Jonathan D Casey, et al.
Pageof 7